Brief: Cullinan Therapeutics Q1 Operating Expenses USD 53.697 Million
May 07 (Reuters) - Cullinan Therapeutics Q1 net income USD -49.661 million. Q1 operating income USD -53.697 million vs. IBES estimate USD -56.6 million Q1 cash & investments USD 393.3 million